Matly David
Inhibrx Biosciences, Inc. · President
Matly David is listed in filings as President at Inhibrx Biosciences, Inc.. This profile follows SEC Form 4 activity through Apr 27, 2026, including 2 public disclosures. Recent filings connect the profile to Inhibrx Biosciences, Inc. (INBX). The current snapshot covers public activity from Apr 2, 2025 to Apr 27, 2026. Reported amounts are shown as $702.5K to $6.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||